Cargando…
Steroid exposure and outcome in COVID-19 pneumonia
BACKGROUND: Corticosteroids are used to treat COVID-19 pneumonia. However, the optimal dose is unclear. This study describes the association between corticosteroid exposure with disease severity and outcome in COVID-19 pneumonia. METHODS: This is a single-centre retrospective, observational study in...
Autores principales: | Remmington, Christopher, Barrett, Nicholas A, Agarwal, Sangita, Lams, Boris, Collins, Patrick, Camarda, Valentina, Meadows, Chris, Hanks, Fraser, Sanderson, Barnaby, Retter, Andrew, Camporota, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886648/ https://www.ncbi.nlm.nih.gov/pubmed/36744291 http://dx.doi.org/10.1016/j.bjao.2023.100128 |
Ejemplares similares
-
Phenotypes of severe COVID-19 ARDS receiving extracorporeal membrane oxygenation
por: Zhang, Joe, et al.
Publicado: (2021) -
Improved oxygenation with inhaled milrinone in mechanically ventilated patients with severe COVID-19
por: Vogel, Dominik J., et al.
Publicado: (2021) -
Veno-venous extracorporeal membrane oxygenation in coronavirus disease 2019: a case series
por: Zhang, Joe, et al.
Publicado: (2020) -
Clinical impact of screening computed tomography in extracorporeal membrane oxygenation: a retrospective cohort study
por: Collins, Patrick D., et al.
Publicado: (2023) -
Restrictive Transfusion Practice in Adults Receiving Venovenous Extracorporeal Membrane Oxygenation: A Single-Center Experience
por: Doyle, Andrew J., et al.
Publicado: (2020)